- Home
- Equipment
- north america
- interventional vascular
Show results for
Refine by
Interventional Vascular Equipment Supplied In North America
10 equipment items found
Manufactured by:QXMedical based inMontreal, QUEBEC (CANADA)
The QXMédical Boosting Catheter is the next generation guide extension catheter offering an expanded indication for fluid delivery. The Boosting Catheter is designed for use with guiding catheters and sheaths to assist delivery and exchange of interventional devices in coronary and peripheral vessels. The catheter offers exceptional trackability along with an atraumatic tip design and ...
Manufactured by:EDM Medical Solutions based inNorth Miami, FLORIDA (USA)
The telescopic ultrasound cover allows for a quick and seamless application of the cover over the ultrasound transducer. Telescopic folding suits both 1-person and 2-person setup protocols, and will help you save time before and after each ...
Manufactured by:Image Diagnostics, Inc. (IDI) based inFitchburg, MASSACHUSETTS (USA)
The Aspect ISR G3 is the flagship of the Aspect™ Series table line; designed to be the preferred imaging solution during interventional and vascular procedures. Featuring true iso-centric lateral roll – anatomy on the iso axis remains centered in the fluoroscopic field of ...
Manufactured by:Image Diagnostics, Inc. (IDI) based inFitchburg, MASSACHUSETTS (USA)
The 100-4T is designed to be the preferred imaging solution during interventional and vascular procedures. The 100-4T provides longitudinal tabletop float of 32 inches (81.2 cm) in a very compact platform enabling comprehensive coverage throughout the anatomical imaging area without C-arm movement – and does so in a table with an ideal overall length of ...
Manufactured by:Adient Medical, Inc. based inPearland, TEXAS (USA)
Although conventional metal IVC filters can reduce the incidence of PE to 1-2%, many are fraught with mounting complications as they remain in the body for prolonged duration. Most IVC filters are placed with the intention to be retrieved within weeks as recommended by the FDA. However, only a small percentage of patients (4-7% in statewide studies) return for the subsequent retrieval procedure. ...
Manufactured by:Revotek Co., Ltd. based inLewes, DELAWARE (USA)
It is estimated by the World Health Organization that the current global prevalence of advanced vascular disease is ~175mm people and increasing. One of the most common clinical interventions to treat advanced vascular disease is the replacement of stenotic or occluded arteries with vascular grafts. This is often accomplished ...
Manufactured by:Siemens Healthcare GmbH based inErlangen, GERMANY
The CorPath System is the first FDA-cleared and CE marked robotic platform designed for interventional physicians. During a CorPath Robotic-assisted intervention, physicians sit in a radiation-shielded workstation and use a set of joysticks and touchscreen controls that translate the physician’s movements into device control. Robotic-assisted intervention enables precise measurement of ...
Manufactured by:U.S. Stem Cell, Inc. (USRM) based inSunrise, FLORIDA (USA)
U.S. Stem Cell’s lead product candidate is MyoCell®, a muscle stem cell therapy that is intended to improve cardiac function months or even years after a patient has suffered severe heart damage due to a heart attack. The procedure involves a physician removing a small amount of muscle from the patient’s thigh. From this muscle specimen, muscle stem cells (also called myoblasts) ...
Manufactured by:Axio Biosolutions Pvt Ltd based inAhmedabad,, INDIA
The Axiostat vascular variant is proven to be effective on such patients at high-risk of uncontrolled bleeding due to the blood thinners/anticoagulants during sheath removal with quick haemostasis. Axiostat Vascular can be used in both femoral and radial procedures and helps in preserving the artery maintaining arterial patency and has zero reported cases of occlusion. Also, Axiostat has worked ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
IMS2186 is an anti-choroidal neovascularization (CNV) agent that inhibits angiogenesis upstream of VEGF. IMS2186 can arrest cancer cell cycle in G2/M phase, thus exerting anti-proliferation and anti-angiogenesis effects. IMS2186 has no intraocular toxicity and reduces the amount of eye leakage and diseased ...